TD Cowen Trims Molina Healthcare (NYSE:MOH) Target Price to $412.00

Molina Healthcare (NYSE:MOH) had its price target lowered by TD Cowen from $453.00 to $412.00 in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

MOH has been the subject of several other reports. Stephens reaffirmed an equal weight rating and issued a $390.00 price objective on shares of Molina Healthcare in a report on Thursday, April 25th. Wells Fargo & Company lowered their price objective on shares of Molina Healthcare from $410.00 to $375.00 and set an equal weight rating for the company in a research report on Monday. Truist Financial lifted their price target on Molina Healthcare from $435.00 to $460.00 and gave the company a buy rating in a research note on Tuesday, February 20th. Barclays dropped their price objective on Molina Healthcare from $437.00 to $430.00 and set an equal weight rating for the company in a research report on Thursday, April 25th. Finally, StockNews.com cut Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare has an average rating of Hold and a consensus target price of $398.55.

Molina Healthcare Stock Performance

Molina Healthcare stock traded up $0.13 during trading hours on Tuesday, hitting $339.68. The company had a trading volume of 373,104 shares, compared to its average volume of 402,516. The firm has a 50-day moving average of $384.15 and a 200 day moving average of $371.76. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The firm has a market cap of $19.91 billion, a PE ratio of 18.43, a PEG ratio of 1.04 and a beta of 0.54. Molina Healthcare has a one year low of $266.35 and a one year high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The company had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. During the same quarter last year, the company earned $5.81 earnings per share. The firm’s quarterly revenue was up 21.9% compared to the same quarter last year. On average, sell-side analysts expect that Molina Healthcare will post 23.59 earnings per share for the current year.

Insider Activity

In related news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now owns 11,207 shares in the company, valued at $4,494,567.35. The disclosure for this sale can be found here. In the last three months, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.10% of the stock is currently owned by insiders.

Institutional Trading of Molina Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MOH. Mediolanum International Funds Ltd bought a new position in Molina Healthcare in the first quarter worth approximately $9,911,000. BI Asset Management Fondsmaeglerselskab A S raised its holdings in Molina Healthcare by 69.5% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company’s stock worth $4,851,000 after buying an additional 4,840 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Molina Healthcare by 6.8% in the first quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after buying an additional 31 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Molina Healthcare by 44.0% during the first quarter. Nordea Investment Management AB now owns 26,244 shares of the company’s stock valued at $10,852,000 after buying an additional 8,025 shares during the last quarter. Finally, Fidelis Capital Partners LLC bought a new stake in shares of Molina Healthcare during the first quarter worth about $151,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.